An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds. Nemolizumab is a man-made, injectable antibody that acts against the protein that has been identified as playing a part in eczema, the international team of researchers said. “The treatments for atopic dermatitis [eczema]…

© 2017 Klinik Mediviron Ara Damansara

Close
error: Content is protected !!